Tau Investment Holdings Pte. Ltd., a promoter of J.B. Chemicals & Pharmaceuticals, has seen the release of encumbrance on its shares. The release, effective from January 21, 2026, follows the fulfillment of certain covenants and restrictions related to a facilities agreement. This move alters the shareholding structure, with no shares now encumbered.
Encumbrance Release Details
An encumbrance on shares held by Tau Investment Holdings Pte. Ltd. in J.B. Chemicals & Pharmaceuticals has been officially released. This decision was made on January 21, 2026, impacting the overall share capital structure. The release stems from fulfilling specific terms within a facilities agreement previously in place.
Previous Encumbrance Circumstances
The previous encumbrance was tied to covenants in a facilities agreement. These stipulations covered restrictions and requirements linked to equity shares of J.B. Chemicals & Pharmaceuticals held by Tau Investment. With these covenants now addressed, restrictions have been lifted, changing Tau Investment’s shareholding status.
Impact on Shareholding
As a result of the release, 0.00% of shares are now encumbered by Tau Investment Holdings Pte. Ltd. This represents a shift from the previous state where 47.55% of the shares held by Tau Investment were subject to encumbrance. The alteration reflects compliance with financial ratios and restrictions, resulting in the elimination of security concerns on its entire shareholding.
Source: BSE
